Desjardins Assurances now reimburses Avitia’s Follow It® liquid biopsy test performed by OncoHelix across Canada.
This milestone makes advanced cancer testing more affordable and accessible for Desjardins members through the Cancer Care Focus initiative.
Pedestrian deaths are skyrocketing - we need to protect people *outside* of vehicles too! Join @ConsumerReports in supporting new @NHTSAgov efforts to protect pedestrians from life-threatening injuries. https://t.co/w7MbZJ9rMX
Brb, on our way to supercharge #PrecisionOncology. 🙋♂️ An exciting day for @imagia_ai as we merge with @CanexiaHealth, a leader in #genomics-based cancer treatment testing solutions.
Together, we can supercharge #PrecisionOncology. 🚀
Excited to announce this #merger to accelerate access to #genomics based #cancer treatment testing by combining @CanexiaHealth’s advanced molecular cancer solutions with @Imagia’s #AI expertise.
https://t.co/vR2RplHVd7
Join our Director of #Oncology, @KKafi, for a panel discussing the latest innovation in #ClinicalTrial design and technology. Part of the #Cancer Clinical Trials and #RWE Conf, advocating to increase patient access to reputable #CancerTrials.
https://t.co/IwLrLfZFbZ
#LCAM
“I wear my #PinkRibbon with the hope that our next generation of women have better means to win the fight against #BreastCancer.”
Our Director of Oncology, Kam Kafi, and his daughter wear pink for the cause! What a way to close off #BreastCancerAwarenessMonth 💪💞
Health is becoming digital health, encompassing everything from #EHRs to #telemedicine and #mHealth — spurred on by the pandemic. The next evolution will involve #AI, but beyond the hype, how, when and where does it fit in for #clinicians? 💡https://t.co/BwePL59Suk